ASCENTAGE

06855

----

Current ValuationThe current P/E ratio is -6.50, within the reasonable range, cheaper than 30.62% of the time in the past 5 years, and the industry ranks 39/78, the industry Median -5.08.

-6.5xP/E

Stock priceHK$29.30Earnings per shareHK$-4.51

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

0155310465620

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
09926HKAKESO	-86.86x	75.72%	HK$96.72B
09688HKZAI LAB	-14.64x	378.87%	HK$21.61B
01877HKJUNSHI BIO	-37.31x	85.34%	HK$17.27B
09606HKDUALITYBIO-B	-9.54x	85.62%	HK$15.80B
07666HKMETIS TECHBIO-P	-34.23x	96.71%	HK$13.93B
01952HKEVEREST MED	-188.42x	324.72%	HK$11.70B
02627HKAB&B BIO-TECH-B	-46.87x	--	HK$11.54B
06855HKASCENTAGE	-6.50x	18.77%	HK$10.99B
02595HKGENFLEET-B	-6.82x	78.34%	HK$10.34B
06938HKRIBOLIFE-B	-45.93x	29.85%	HK$8.97B
09887HKLEADS BIOLABS-B	-28.80x	8.66%	HK$8.85B
02493HKMABWELL-B	-7.96x	--	HK$8.62B
02616HKCSTONE PHARMA-B	-16.47x	1.77%	HK$7.95B
01672HKASCLETIS-B	-10.35x	78.53%	HK$7.05B
01779HKLONGBIO-B	-27.52x	--	HK$6.85B
02171HKCARSGEN-B	-66.50x	51.05%	HK$6.83B
09966HKALPHAMAB-B	-33.61x	--	HK$6.81B
02335HKMICOT PHARMA-B	-15.05x	37.52%	HK$6.32B
06872HKTENNOR THERAP-B	-34.71x	--	HK$5.57B
02256HKABBISKO-B	-10.29x	301.05%	HK$5.53B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.